- Home
- ELS vs QGEN Comparison
ELS vs QGEN Comparison
Compare ELS & QGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELS
- QGEN
- Stock Information
- Founded
- ELS 1992
- QGEN 1986
- Country
- ELS United States
- QGEN Netherlands
- Employees
- ELS N/A
- QGEN N/A
- Industry
- ELS Real Estate Investment Trusts
- QGEN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ELS Real Estate
- QGEN Health Care
- Exchange
- ELS Nasdaq
- QGEN Nasdaq
- Market Cap
- ELS 12.0B
- QGEN 10.7B
- IPO Year
- ELS 1993
- QGEN 1996
- Fundamental
- Price
- ELS $61.45
- QGEN $43.10
- Analyst Decision
- ELS Buy
- QGEN Buy
- Analyst Count
- ELS 11
- QGEN 7
- Target Price
- ELS $70.86
- QGEN $50.68
- AVG Volume (30 Days)
- ELS 2.4M
- QGEN 1.2M
- Earning Date
- ELS 10-22-2025
- QGEN 11-04-2025
- Dividend Yield
- ELS 3.39%
- QGEN 3.43%
- EPS Growth
- ELS 2.36
- QGEN 334.36
- EPS
- ELS 1.99
- QGEN 1.85
- Revenue
- ELS $1,535,911,000.00
- QGEN $2,070,781,000.00
- Revenue This Year
- ELS $1.28
- QGEN $7.37
- Revenue Next Year
- ELS $3.93
- QGEN $5.65
- P/E Ratio
- ELS $30.52
- QGEN $23.78
- Revenue Growth
- ELS 0.93
- QGEN 5.32
- 52 Week Low
- ELS $58.15
- QGEN $37.63
- 52 Week High
- ELS $73.67
- QGEN $51.88
- Technical
- Relative Strength Index (RSI)
- ELS 51.17
- QGEN 27.09
- Support Level
- ELS $60.36
- QGEN $43.26
- Resistance Level
- ELS $61.24
- QGEN $47.39
- Average True Range (ATR)
- ELS 1.14
- QGEN 1.06
- MACD
- ELS -0.10
- QGEN -0.62
- Stochastic Oscillator
- ELS 56.12
- QGEN 4.06
About ELS Equity Lifestyle Properties Inc.
Equity Lifestyle Properties is a residential REIT that focuses on owning manufactured housing, residential vehicle communities, and marinas. The company currently has a portfolio of 455 properties across the U.S. with a higher concentration in the Sunbelt region with 38% of the company's properties located in Florida, 12% in Arizona, and 8% in California. Equity Lifestyle targets owning properties in attractive retirement destinations with over 70% of the company's properties either being age-restricted or having an average resident age over 55.
About QGEN Qiagen N.V.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2024 sales), followed by EMEA (33%), and the Asia-Pacific (15%).